242
Views
16
CrossRef citations to date
0
Altmetric
Perspective

Timing use of novel anti-epileptic drugs: is earlier better?

, , , , &
Pages 945-954 | Received 30 Apr 2019, Accepted 24 Jun 2019, Published online: 01 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Jéssica Domingos da Silva, Lucio Mendes Cabral & Valéria Pereira de Sousa. (2022) Stability Indicating Methods for Determination of Third Generation Antiepileptic Drugs and Their Related Substances. Critical Reviews in Analytical Chemistry 52:7, pages 1524-1536.
Read now
Darshan Mehta, Matthew Davis, Andrew J Epstein, Brian Wensel, Todd Grinnell & G Rhys Williams. (2021) Comparative Economic Outcomes in Patients with Focal Seizure Initiating First-Line Eslicarbazepine Acetate Monotherapy versus Generic Antiseizure Drugs. ClinicoEconomics and Outcomes Research 13, pages 251-261.
Read now
Darshan Mehta, Matthew Davis, Andrew J. Epstein, Brian Wensel, Todd Grinnell, Andrew Thach & G. Rhys Williams. (2021) Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam as their first adjunctive ASD. Journal of Medical Economics 24:1, pages 939-948.
Read now
Stefano de Biase, Gian Luigi Gigli & Mariarosaria Valente. (2020) Brivaracetam for the treatment of focal-onset seizures: pharmacokinetic and pharmacodynamic evaluations. Expert Opinion on Drug Metabolism & Toxicology 16:10, pages 853-863.
Read now
Jiyuan Li, Meizhen Sun & Xuefeng Wang. (2020) The adverse-effect profile of lacosamide. Expert Opinion on Drug Safety 19:2, pages 131-138.
Read now

Articles from other publishers (11)

Yang Jin, Ranran Zhang, Jing Jiang & Xuewu Liu. (2023) Efficacy and tolerability of lacosamide as adjunctive therapy in patients with focal-onset seizures: an observational, prospective study. Acta Neurologica Belgica 123:3, pages 1081-1087.
Crossref
Youjie Zeng, Si Cao & Heng Yang. (2023) Roles of gut microbiome in epilepsy risk: A Mendelian randomization study. Frontiers in Microbiology 14.
Crossref
Yue Li, Na Dong, Yu‐Xin Qin, Hao‐Ran Dai, Ya‐Hui Hu, Yue‐Tao Zhao, Hong‐Li Guo, Yuan‐Yuan Zhang, Jing Chen, Xiao‐Peng Lu & Feng Chen. (2022) Therapeutic drug monitoring of perampanel in children diagnosed with epilepsy: Focus on influencing factors on the plasma concentration‐to‐dose ratio. Epilepsia Open 7:4, pages 737-746.
Crossref
Kaleem Imdad, Turki Abualait, Ammara Kanwal, Ziyad Tareq AlGhannam, Shahab Bashir, Anum Farrukh, Sahir Hameed Khattak, Raidah Albaradie & Shahid Bashir. (2022) The Metabolic Role of Ketogenic Diets in Treating Epilepsy. Nutrients 14:23, pages 5074.
Crossref
Hyungjong Park & Joonsang Yoo. (2022) Use of Non-Vitamin K Dependent Oral Anticoagulant in Ischemic Stroke. Journal of the Korean Neurological Association 40:1, pages 1-14.
Crossref
Darshan Mehta, Drishti Shah, Vibha Desai, Mitch DeKoven, Ronald DePue, G. Rhys Williams & Dana Saffel. (2021) Healthcare Resource Utilization Among Patients with Focal Seizures Treated with Eslicarbazepine Acetate in the US Long-Term Care Setting: A Retrospective Claims Database Analysis. Neurology and Therapy 10:2, pages 673-691.
Crossref
Jan Steffel, Ronan Collins, Matthias Antz, Pieter Cornu, Lien Desteghe, Karl Georg Haeusler, Jonas Oldgren, Holger Reinecke, Vanessa Roldan-Schilling, Nigel Rowell, Peter Sinnaeve, Thomas Vanassche, Tatjana Potpara, A John Camm, Hein Heidbüchel, Gregory Y H Lip, Thomas Deneke, Nikolaos Dagres, Giuseppe Boriani, Tze-Fan Chao, Eue-Keun Choi, Mellanie True Hills, Itamar de Souza Santos, Deirdre A Lane, Dan Atar, Boyoung Joung, Oana Maria Cole & Mark Field. (2021) 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. EP Europace 23:10, pages 1612-1676.
Crossref
Wenqiu Yang, Xianjun Zhang, Jin Long, Qian Wu & Yanbing Han. (2020) Prediction of the recurrence risk in patients with epilepsy after the withdrawal of antiepileptic drugs. Epilepsy & Behavior 110, pages 107156.
Crossref
Emilio Perucca, Martin J Brodie, Patrick Kwan & Torbjörn Tomson. (2020) 30 years of second-generation antiseizure medications: impact and future perspectives. The Lancet Neurology 19:6, pages 544-556.
Crossref
Bshra Ali A. Alsfouk, Martin J. Brodie, Matthew Walters, Patrick Kwan & Zhibin Chen. (2020) Tolerability of Antiseizure Medications in Individuals With Newly Diagnosed Epilepsy. JAMA Neurology 77:5, pages 574.
Crossref
Zhibin Chen, Martin J. Brodie & Patrick Kwan. (2020) What has been the impact of new drug treatments on epilepsy?. Current Opinion in Neurology, pages 1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.